Abstract

AimExecutive function (EF) is considered a core attention deficit hyperactivity disorder (cADHD) symptom in adults and, more recently, sluggish cognitive tempo (SCT). Despite considerable controversy around the role of SCT symptoms in the diagnosis of attention deficit hyperactivity disorder (ADHD), some scholars have suggested that SCT symptoms are a subset of the ADHD syndrome, whereas others have suggested that SCT is an entirely unique type of attention disorder. Therefore, we looked to characterize the impact of treatment as usual (TAU) with medication and psychoeducation on the functional impairments related to EF and SCT, and related functional impairments in adults with ADHD. We aim to clarify if the combination of TAU and modular ADHD therapy (TAUTx) further improves these symptoms. The goal is to assess the validity of self-reporting assessment of symptoms adopted in the present for the monitoring of treatment in this population. MethodsWe implemented the inclusion and exclusion criteria at the onset of the clinic. This prospective cohort case series study is designed to see the difference with self-reporting scales for EF, SCT, and cADHD symptoms in TAU and TAUTx. The STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) checklist was used to provide transparency in reporting the data.ResultsAdults with ADHD showed a significant improvement with TAU in EF (p=0.001), cADHD (p=0.007), and SCT (p=0.002). Furthermore, TAUTx improved areas of EF (p=0.001), cADHD (p=0.004), and SCT (p=0.002). We saw a significant benefit from starting/optimizing medications in the treatment of ADHD along with psychoeducation. Self-reporting scales appeared to be reliable for monitoring the symptoms of ADHD and related dysfunction and were consistent with the Clinical Global Impressions Scale.ConclusionsAdult ADHD patients reported significant benefit from TAU for aspects of impairment in EF and SCT. They require ongoing medication prescribing and “tailoring” through optimization. Psychoeducation is an effective form of therapy in these patients with or without the addition of adult ADHD modular therapy. Self-reporting is valid for monitoring and providing transparency in patient care.

Highlights

  • Background/rationaleThe prevalence of adult attention deficit hyperactivity disorder (ADHD) can be 2.9-16.4% [1] or 15.817.4% [2], depending on studies

  • Despite considerable controversy around the role of sluggish cognitive tempo (SCT) symptoms in the diagnosis of attention deficit hyperactivity disorder (ADHD), some scholars have suggested that SCT symptoms are a subset of the ADHD syndrome, whereas others have suggested that SCT is an entirely unique type of attention disorder

  • We looked to characterize the impact of treatment as usual (TAU) with medication and psychoeducation on the functional impairments related to Executive function (EF) and SCT, and related functional impairments in adults with ADHD

Read more

Summary

Introduction

The prevalence of adult attention deficit hyperactivity disorder (ADHD) can be 2.9-16.4% [1] or 15.817.4% [2], depending on studies. ADHD is a disorder characterized by deficits in the attention span (inattention), impulsive behaviors (impulsivity), and increased level of activity (hyperactivity) [3]. The behavioral problems that result from untreated ADHD can affect personal and social relationships, academic functioning, and work performance, leading to a lower quality of life [2]. The lifetime prevalence of having comorbidity is 60-80% [4], which confounds the diagnoses and complicates the treatment of ADHD [5]. Standardized screening can assess the functional aspects of ADHD and their comorbidities.

Objectives
Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call